| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 26,818 | |||
| Short-term investments | 49,244 | |||
| Prepaid expenses and other current assets | 5,879 | |||
| Total current assets | 81,941 | |||
| Operating lease right-of-use assets, net | 160 | |||
| Property and equipment, net | 970 | |||
| Restricted cash | 1,412 | |||
| Other non-current assets | 61 | |||
| Total assets | 84,544 | |||
| Accounts payable | 3,576 | |||
| Accrued liabilities | 6,309 | |||
| Operating lease liability, current portion | 160 | |||
| Other current liabilities | 371 | |||
| Total current liabilities | 10,416 | |||
| Other non-current liabilities | 261 | |||
| Total liabilities | 10,677 | |||
| Convertible preferred stock 0.0001 par value - 157,657,729 shares authorized at september 30, 2025 and december 31, 2024, respectively, 157,657,729 and 116,716,142 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively (liquidation preference 275,611 and 210,328 at september 30, 2025 and december 31, 2024, respectively) | 257,004 | |||
| Additional paid-in capital | 9,679 | |||
| Accumulated deficit | -192,816 | |||
| Total stockholders' deficit | -183,137 | |||
| Total liabilities, convertible preferred stock, and stockholders' deficit | 84,544 | |||
Evommune, Inc. (EVMN)
Evommune, Inc. (EVMN)